6th-Annual-Interdisciplinary-Prostate-Cancer-Congress课件.pptxVIP

下载本文档

3
0
约2.54千字
约 47页
2019-04-27 发布于湖北
举报
版权申诉

6th-Annual-Interdisciplinary-Prostate-Cancer-Congress课件.pptx

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

6th Annual Interdisciplinary Prostate Cancer Congress;Screening for Prostate Cancer – The PSA Controversy;US Preventive Services Task Force (USPSTF) Screening Recommendations;National Comprehensive Cancer Network (NCCN) Screening Guidelines;American Cancer Society (ACS) Screening Guidelines;American Urological Association (AUA) Screening Guidelines;PSA-Based Prostate Screening;Implications for Patient Care;Active Surveillance—Current Status and Future Directions;Watchful Waiting vs Active Surveillance / Active Monitoring;National Comprehensive Cancer Network (NCCN) Guidelines on Active Surveillance;Summary of Active Surveillance Studies;Active Surveillance: Current Approach;New Endocrine Options for Advanced Prostate Cancer;Abiraterone Phase III Trials: COU-AA-301 and COU-AA-302;Enzalutamide Phase III AFFIRM Trial;Second-Line Hormonal Therapy: Remaining Issues;Endocrine Agents in Development;Evolving Approaches for Chemotherapy for Advanced Prostate Cancer;Docetaxel Hormone-Refractory Prostate Cancer;Phase III Trials of Docetaxel Combinations;Phase III TROPIC Registration Study of Cabazitaxel vs Mitoxantrone in Docetaxel-Resistant Patients;Advances in Immunotherapy;Rationale for Immunologic Approaches in Prostate Cancer;Immunotherapies to Date…;Brief Summary of Immunologic Trials in Prostate Cancer;Conclusions on Immunologic Approaches in Prostate Cancer;Novel Therapies and Bone-Targeted Therapy;Skeletal-Related Events in Cancer;Phase III Trial of Denosumab vs Zoledronic Acid in Castration-Resistant Prostate Cancer;Phase III Trial of Denosumab vs Zoledronic Acid Results;FDA-Approved Bone-Targeting Radionuclides for the Treatment of Bone Metastases;Bone-Targeting Radionuclides for Patients with Prostate Cancer Bone Metastases;Cabozantinib in Bone Metastatic Prostate Cancer;Conclusions on Novel Therapies and Bone-Targeted Therapies;Can We Combine Novel Agents in the Management of Advanced Prostate Cancer?;Combination Therapy in Metastatic Castration-